Literature DB >> 8274816

An international collaborative study of the epidemiology of esophageal atresia or stenosis.

E Robert1, O Mutchinick, P Mastroiacovo, L B Knudsen, A K Daltveit, E E Castilla, P Lancaster, B Källén, G Cocchi.   

Abstract

Epidemiologic data were analyzed for a total of 2,693 infants with esophageal atresia registered in nine congenital malformation registries around the world. The average recorded prevalence at birth was 2.6 per 10,000 births, with a significant variability among programs--and sometimes within a program--and a maximum prevalence of above 3 per 10,000 births. Clusters of infants with esophageal atresia were observed but may be random. An increasing rate was seen during the period 1965 to 1975 (Norway, South America, Sweden). The type of esophageal atresia was specified in only 439 cases, but no major differences were seen in the epidemiologic characteristics of infants with the most common type (distal fistula) and infants with other types. There was an excess of low birth weight and preterm birth, and infants with esophageal atresia had a birth weight 500 to 1,000 g less than normal infants in each gestational week. There was an excess of twins, apparently mainly or exclusively due to monozygotic twinning, but in only two pairs did both twins have esophageal atresia. There was no effect seen of maternal age, but low parity, irrespective of maternal age, was associated with an increased risk for esophageal atresia. Infant survival varied among programs and depended heavily on associated malformations. Among 1,107 sibs born before the proband and 385 born after the proband, only 25 (1.7%) had a serious malformation; three had esophageal atresia. In 57.3% of the infants with esophageal atresia, no other malformations were present, in 36.4% other major malformations were recorded, and in 6.3% there were chromosomal anomalies. The malformations present associated with esophageal atresia were analyzed: a large proportion entered the constellation sometimes called "caudal mesoderm spectrum of malformations": VATER, Potter, and caudal regression sequences.

Entities:  

Mesh:

Year:  1993        PMID: 8274816     DOI: 10.1016/0890-6238(93)90085-l

Source DB:  PubMed          Journal:  Reprod Toxicol        ISSN: 0890-6238            Impact factor:   3.143


  12 in total

1.  Aspects of esophageal atresia in a population-based setting: incidence, mortality, and cancer risk.

Authors:  Jenny Oddsberg; Yunxia Lu; Jesper Lagergren
Journal:  Pediatr Surg Int       Date:  2011-10-22       Impact factor: 1.827

Review 2.  Oesophageal atresia, tracheo-oesophageal fistula, and the VACTERL association: review of genetics and epidemiology.

Authors:  C Shaw-Smith
Journal:  J Med Genet       Date:  2005-11-18       Impact factor: 6.318

Review 3.  Respiratory Care of Infants and Children with Congenital Tracheo-Oesophageal Fistula and Oesophageal Atresia.

Authors:  Sara C Sadreameli; Sharon A McGrath-Morrow
Journal:  Paediatr Respir Rev       Date:  2015-03-03       Impact factor: 2.726

4.  Maternal periconceptional exposure to cigarette smoking and alcohol and esophageal atresia +/- tracheo-esophageal fistula.

Authors:  Donna L Wong-Gibbons; Paul A Romitti; Lixian Sun; Cynthia A Moore; Jennita Reefhuis; Erin M Bell; Andrew F Olshan
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2008-11

Review 5.  Advances in the treatment of oesophageal atresia over three decades: the 1970s and the 1990s.

Authors:  Jillian Orford; Daniel T Cass; Martin J Glasson
Journal:  Pediatr Surg Int       Date:  2004-05-18       Impact factor: 1.827

6.  Prevalence of esophageal atresia among 18 international birth defects surveillance programs.

Authors:  Natasha Nassar; Emanuele Leoncini; Emmanuelle Amar; Jazmín Arteaga-Vázquez; Marian K Bakker; Carol Bower; Mark A Canfield; Eduardo E Castilla; Guido Cocchi; Adolfo Correa; Melinda Csáky-Szunyogh; Marcia L Feldkamp; Babak Khoshnood; Danielle Landau; Nathalie Lelong; Jorge S López-Camelo; R Brian Lowry; Robert McDonnell; Paul Merlob; Julia Métneki; Margery Morgan; Osvaldo M Mutchinick; Miland N Palmer; Anke Rissmann; Csaba Siffel; Antonin Sìpek; Elena Szabova; David Tucker; Pierpaolo Mastroiacovo
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2012-09-03

7.  Survival of infants born with esophageal atresia among 24 international birth defects surveillance programs.

Authors:  Jane C Bell; Gareth Baynam; Jorieke E H Bergman; Eva Bermejo-Sánchez; Lorenzo D Botto; Mark A Canfield; Saeed Dastgiri; Miriam Gatt; Boris Groisman; Paula Hurtado-Villa; Karin Kallen; Babak Khoshnood; Victoria Konrad; Danielle Landau; Jorge S Lopez-Camelo; Laura Martinez; Margery Morgan; Osvaldo M Mutchinick; Amy E Nance; Wendy Nembhard; Anna Pierini; Anke Rissmann; Xiaoyi Shan; Antonin Sipek; Elena Szabova; Giovanna Tagliabue; Lyubov S Yevtushok; Ignacio Zarante; Natasha Nassar
Journal:  Birth Defects Res       Date:  2021-03-18       Impact factor: 2.661

8.  Whole genome sequencing of familial isolated oesophagus atresia uncover shared structural variants.

Authors:  Joakim Klar; Helene Engstrand-Lilja; Khurram Maqbool; Jonas Mattisson; Lars Feuk; Niklas Dahl
Journal:  BMC Med Genomics       Date:  2020-06-26       Impact factor: 3.063

Review 9.  Heritability and De Novo Mutations in Oesophageal Atresia and Tracheoesophageal Fistula Aetiology.

Authors:  Erwin Brosens; Rutger W W Brouwer; Hannie Douben; Yolande van Bever; Alice S Brooks; Rene M H Wijnen; Wilfred F J van IJcken; Dick Tibboel; Robbert J Rottier; Annelies de Klein
Journal:  Genes (Basel)       Date:  2021-10-10       Impact factor: 4.096

10.  Histological, immunohistochemical and transcriptomic characterization of human tracheoesophageal fistulas.

Authors:  Erwin Brosens; Janine F Felix; Anne Boerema-de Munck; Elisabeth M de Jong; Elisabeth M Lodder; Sigrid Swagemakers; Marjon Buscop-van Kempen; Ronald R de Krijger; Rene M H Wijnen; Wilfred F J van IJcken; Peter van der Spek; Annelies de Klein; Dick Tibboel; Robbert J Rottier
Journal:  PLoS One       Date:  2020-11-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.